Market Research Life Sciences Market Research Pharmaceuticals Market Research Vaccines Market Research

Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Admi

Best Price Guarantee Length Publisher Published Date SKU
from $3,599 200 Pages BlueWeave Consulting August, 2023 BLWC18285261
Best Price Guarantee
Price from $3,599
Length 200 Pages
Publisher BlueWeave Consulting
Published Date August, 2023
SKU BLWC18285261

Europe Veterinary Vaccine Market, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines); By Animal Type (Livestock (Poultry, Aqua, Ruminants, Swine), Companion (Canine, Feline)); By Route of Administration (Subcutaneous, Intramuscular, Intranasal); By Country (Germany, United Kingdom, Italy, France, Spain, Belgium, Russia, Netherlands, Rest of Europe), Competitive Landscape & Forecast, 2019–2029


Europe Veterinary Vaccine Market Size Set to Reach USD 4.5 Billion by 2029

Europe veterinary vaccine market is flourishing due to increasing pet ownership, rising awareness about animal health, a growing demand for livestock products, and government initiatives to control and prevent animal diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Europe veterinary vaccine market size at USD 3,208.92 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the Europe veterinary vaccine market size to grow at a CAGR of 5.71% reaching a value of USD 4,477.33 million by 2029. The European veterinary vaccination industry is expanding rapidly. Increasing awareness about animal health and illness prevention is driving the demand for vaccines. Vaccine manufacturers are always developing to create more effective and safer vaccines. Government actions and laws are helping to expand the market by encouraging vaccine research and development. A burgeoning pet population and the need to protect animals from disease are driving the market. Vaccination programs are being implemented in veterinary clinics and animal husbandry establishments. Overall, the Europe veterinary vaccine industry has a bright future, with consistent breakthroughs in animal healthcare and illness prevention.

Europe Veterinary Vaccine Market – Overview

Veterinary vaccines are essential tools in safeguarding the health and well-being of animals. These vaccines are specifically designed to prevent or reduce the incidence of various infectious diseases in animals, ranging from livestock, such as cattle, pigs, and poultry, to domestic pets like dogs and cats. By stimulating the animal's immune system, vaccines create a protective response against harmful pathogens, such as viruses and bacteria, thereby preventing disease transmission. Regular vaccination not only promotes animal welfare but also contributes to public health by reducing zoonotic disease risks. Veterinary vaccines play a pivotal role in maintaining the health of animal populations and supporting sustainable agricultural practices.

Impact of COVID-19 on Europe Veterinary Vaccine Market

The COVID-19 pandemic significantly impacted the Europe veterinary vaccine market, driving accelerated growth. As lockdowns were imposed, people spent more time at home, resulting in increased pet adoption rates and heightened awareness of animal health. Veterinarians reported a surge in demand for vaccines to protect companion animals. With disruptions in food supply chains, farmers sought to safeguard livestock health, leading to a rise in demand for livestock vaccines. The pandemic also prompted governments and private sector investment in vaccine research and development. These factors combined to propel the Europe veterinary vaccine market to new heights amid the crisis.

Europe Veterinary Vaccine Market – By Animal Type

By animal type, Europe veterinary vaccine market is split into Livestock and Companion segments. The livestock segment is further divided into Poultry, Aqua, Ruminants, and Swine subsegments. The companion segment is also sub-segmented into Canine and Feline. The livestock segment represents the vaccination needs for various farm animals, contributing significantly to the overall market. The companion segment, on the other hand, includes Canine and Feline sub-segments, catering to vaccination requirements for domestic pets. However, it is the livestock segment that holds a larger share, reflecting the importance of safeguarding and maintaining the health of livestock animals in the European veterinary vaccine market.

Competitive Landscape

Europe veterinary vaccine market is fiercely competitive. Major companies in the market include Zoetis, Ceva Santé Animale, Merck & Co., Inc., Vetoquinol S.A., Boehringer Ingelheim Gmbh, Elanco, Virbac, Heska, and Dechra Pharmaceuticals Plc. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Europe veterinary vaccine market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Europe Veterinary Vaccine Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Europe Veterinary Vaccine Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Europe Veterinary Vaccine Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing pet ownership
3.2.1.2. Growing livestock production
3.2.2. Restraints
3.2.2.1. High research and development costs
3.2.3. Opportunities
3.2.3.1. Rising prevalence of zoonotic diseases
3.2.4. Challenges
3.2.4.1. Stringent regulatory requirements
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Europe Veterinary Vaccine Market Overview
4.1. Market Product & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share & Forecast
4.2.1. By Product
4.2.1.1. Attenuated Live Vaccines
4.2.1.2. Inactivated Vaccines
4.2.1.3. Subunit Vaccines
4.2.1.4. DNA Vaccines
4.2.1.5. Recombinant Vaccines
4.2.2. By Animal Type
4.2.2.1. Livestock
4.2.2.1.1. Poultry
4.2.2.1.2. Aqua
4.2.2.1.3. Ruminants
4.2.2.1.4. Swine
4.2.2.2. Companion
4.2.2.2.1. Canine
4.2.2.2.2. Feline
4.2.2.2.3. Others
4.2.3. By Route of Administration
4.2.3.1. Subcutaneous
4.2.3.2. Intramuscular
4.2.3.3. Intranasal
4.2.4. By Country
4.2.4.1. Germany
4.2.4.2. United Kingdom
4.2.4.3. Italy
4.2.4.4. France
4.2.4.5. Spain
4.2.4.6. Belgium
4.2.4.7. Russia
4.2.4.8. The Netherlands
4.2.4.9. Rest of Europe
5. Germany Veterinary Vaccine Market
5.1. Market Product & Forecast, 2019–2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Product
5.2.2. By Animal Type
5.2.3. By Route of Administration
6. United Kingdom Veterinary Vaccine Market
6.1. Market Product & Forecast, 2019–2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Animal Type
6.2.3. By Route of Administration
7. Italy Veterinary Vaccine Market
7.1. Market Product & Forecast, 2019–2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Animal Type
7.2.3. By Route of Administration
8. France Veterinary Vaccine Market
8.1. Market Product & Forecast, 2019–2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Animal Type
8.2.3. By Route of Administration
9. Spain Veterinary Vaccine Market
9.1. Market Product & Forecast, 2019–2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Animal Type
9.2.3. By Route of Administration
10. Belgium Veterinary Vaccine Market
10.1. Market Product & Forecast, 2019–2029
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Animal Type
10.2.3. By Route of Administration
11. Russia Veterinary Vaccine Market
11.1. Market Product & Forecast, 2019–2029
11.1.1. By Value (USD Million)
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Animal Type
11.2.3. By Route of Administration
12. Netherlands Veterinary Vaccine Market
12.1. Market Product & Forecast, 2019–2029
12.1.1. By Value (USD Million)
12.2. Market Share & Forecast
12.2.1. By Product
12.2.2. By Animal Type
12.2.3. By Route of Administration
13. Rest of Europe Veterinary Vaccine Market
13.1. Market Product & Forecast, 2019–2029
13.1.1. By Value (USD Million)
13.2. Market Share & Forecast
13.2.1. By Product
13.2.2. By Animal Type
13.2.3. By Route of Administration
14. Competitive Landscape
14.1. List of Key Players and Their Offerings
14.2. Europe Veterinary Vaccine Company Market Share Analysis, 2022
14.3. Competitive Benchmarking, By Operating Parameters
14.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
15. Impact of Covid-19 on Europe Veterinary Vaccine Market
16. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
16.1. Zoetis
16.2. Ceva Santé Animale
16.3. Merck & Co., Inc.
16.4. Vetoquinol S.A.
16.5. Boehringer Ingelheim Gmbh
16.6. Elanco
16.7. Virbac
16.8. Heska
16.9. Dechra Pharmaceuticals Plc
16.10. Other Prominent Players
17. Key Strategic Recommendations
18. Research Methodology
18.1. Qualitative Research
18.1.1. Primary & Secondary Research
18.2. Quantitative Research
18.3. Market Breakdown & Data Triangulation
18.3.1. Secondary Research
18.3.2. Primary Research
18.4. Breakdown of Primary Research Respondents, By Region
18.5. Assumptions & Limitations
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Europe Veterinary Vaccine Segmentation
Figure 2 Europe Veterinary Vaccine Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 5 Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 6 Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 7 Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 8 Europe Veterinary Vaccine Market Share, By Country, By Value, 2019–2029
Figure 9 Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 10 Germany Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 11 Germany Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 12 Germany Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 13 United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 14 United Kingdom Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 15 United Kingdom Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 16 United Kingdom Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 17 Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 18 Italy Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 19 Italy Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 20 Italy Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 21 France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 22 France Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 23 France Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 24 France Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 25 Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 26 Spain Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 27 Spain Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 28 Spain Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 29 Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 30 Belgium Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 31 Belgium Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 32 Belgium Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 33 Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 34 Russia Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 35 Russia Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 36 Russia Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 37 Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 38 Netherlands Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 39 Netherlands Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 40 Netherlands Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
Figure 41 Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Figure 42 Rest of Europe Veterinary Vaccine Market Share, By Product, By Value, 2019–2029
Figure 43 Rest of Europe Veterinary Vaccine Market Share, By Animal Type, By Value, 2019–2029
Figure 44 Rest of Europe Veterinary Vaccine Market Share, By Route of Administration, By Value, 2019–2029
List of Tables
Table 1 Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 2 Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 3 Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 4 Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 5 Europe Veterinary Vaccine Market Size, By Country, By Value, 2019–2029
Table 6 Germany Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 7 Germany Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 8 Germany Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 9 Germany Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 10 United Kingdom Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 11 United Kingdom Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 12 United Kingdom Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 13 United Kingdom Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 14 Italy Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 15 Italy Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 16 Italy Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 17 Italy Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 18 France Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 19 France Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 20 France Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 21 France Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 22 Spain Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 23 Spain Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 24 Spain Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 25 Spain Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 26 Belgium Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 27 Belgium Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 28 Belgium Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 29 Belgium Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 30 Russia Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 31 Russia Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 32 Russia Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 33 Russia Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 34 Netherlands Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 35 Netherlands Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 36 Netherlands Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 37 Netherlands Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 38 Rest of Europe Veterinary Vaccine Market Size, By Value (USD Million), 2019–2029
Table 39 Rest of Europe Veterinary Vaccine Market Size, By Product, By Value, 2019–2029
Table 40 Rest of Europe Veterinary Vaccine Market Size, By Animal Type, By Value, 2019–2029
Table 41 Rest of Europe Veterinary Vaccine Market Size, By Route of Administration, By Value, 2019–2029
Table 42 Zoetis Company Overview
Table 43 Zoetis Financial Overview
Table 44 Ceva Santé Animale Company Overview
Table 45 Ceva Santé Animale Financial Overview
Table 46 Merck & Co., Inc. Company Overview
Table 47 Merck & Co., Inc. Financial Overview
Table 48 Vetoquinol S.A. Company Overview
Table 49 Vetoquinol S.A. Financial Overview
Table 50 Boehringer Ingelheim Gmbh Company Overview
Table 51 Boehringer Ingelheim Gmbh Financial Overview
Table 52 Elanco Company Overview
Table 53 Elanco Financial Overview
Table 54 Virbac Company Overview
Table 55 Virbac Financial Overview
Table 56 Heska Company Overview
Table 57 Heska Financial Overview
Table 58 Dechra Pharmaceuticals Plc Company Overview
Table 59 Dechra Pharmaceuticals Plc Financial Overview

$3,599
$4,000
$4,500

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings